Integral Health Asset Management »

4d Molecular Therapeutics In shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.0M 250k 31.86

More positions owned by Integral Health Asset Management

Viking Therapeutics Put Option (VKTX)
Insmed Com Par $.01 (INSM)
Tenet Healthcare Corp Com New (THC)
Boston Scientific Corporation (BSX)
Cytokinetics Com New (CYTK)
Merck & Co (MRK)
Encompass Health Corp (EHC)
Walgreen Boots Alliance (WBA)
Anthem (ELV)
Abbvie (ABBV)
Universal Hlth Svcs CL B (UHS)
Novartis Sponsored Adr (NVS)
Tarsus Pharmaceuticals (TARS)
Moonlake Immunotherapeutics Class A Ord Call Option (MLTX)
Longboard Pharmaceuticals In (LBPH)

View all positions for Integral Health Asset Management

Top funds holding 4d Molecular Therapeutics In

RA Capital Management
BlackRock
VR Adviser
Goldman Sachs Group
Deep Track Capital
BVF
Henderson Group
Viking Global Investors
Vanguard Group
State Street Corporation
Morgan Stanley
Novo A/S
Redmile Group
Geode Capital Management
Eventide Asset Management

View all funds holding 4d Molecular Therapeutics In